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Cardiovascular diseases (CVD) are  the leading cause of mortality globally, accounting for an 
estimated 18 million deaths annually. In high income countries (HICs), 80% of cardiovascular 
deaths are due to myocardial infarctions and strokes. In South Africa, as in the rest of sub-Saharan 
Africa (SSA), the spectrum of CVD is different: largely due to hypertension, cardiomyopathy, 
rheumatic heart disease, pericardial disease and infections of the cardiovascular system.(1) 
Individuals at high risk of CVD may demonstrate raised blood pressure, glucose, and lipids as well 
as being overweight and having obesity; all of which can easily be detected in primary care 
facilities. Identifying those at highest risk of CVD and ensuring they receive appropriate treat-
ment can prevent premature deaths. Access to essential noncommunicable disease medicines 
and basic health technologies in all primary healthcare facilities is essential to ensure that those 
in need receive treatment and counselling.
In the past few years, the burden of hypertension has shifted from HICs to low- and middle-
income countries (LMICs), including sub-Saharan Africa. Elevated blood pressure is accompanied 
by rising obesity trends, with two thirds of South African women and a third of men being 
overweight or obese.(2) In South Africa, the age-standardised death rates for non-communicable 
diseases (NCDs) are now higher than those of HIV/AIDS and tuberculosis combined, with CVD 
being the leading category of NCDs.(3)  Population-based strategies to prevent NCDs are 
progressive and include legislation for the reduction of sodium in processed foods, taxation of 
sugar-sweetened beverages and alcohol, and continued tightening of anti-tobacco regulations.
The South African Heart Journal, since its inception, has been one of the leading journals for 
cardiovascular disease on the African continent. It continues to play an important role in the 
promotion of science, education, advocacy in the cardiovascular space in South Africa and 
beyond. 2019 was no exception as the Journal published important articles, some of which are 
reviewed below.
HYPERTENSION
Capistrant and colleagues examined whether determinants of hypertension vary between Ghana 
and South Africa. They reported that South Africa had higher age-standardised prevalence of 
hypertension (men 76%, women 82%) compared to Ghana (men 57%, women 61%) and that 
odds of hypertension prevalence varied for rural residence and education and between the 2 
countries. They observed consistent differences in awareness of hypertension between countries, 
which were related to educational attainment, income, and weight status by sex. However, 
determinants of control and management of hypertension differed between the 2 countries only 
for women.(4)
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Russel and co-investigators evaluated the utility of admission blood glucose for predicting major adverse 
cardiac events (MACE) during hospitalisation and 6 months’ post-discharge in acute myocardial infarc-
tion (AMI) patients. The highest prevalence of MACE was seen in the high admission glycaemia group, 
which was associated with cardiogenic shock, cardiac failure and death. Following multivariable logistic 
regression analyses of clinical and laboratory parameters associated with mortality, high admission blood 
glucose conferred a significantly increased odds of mortality. The optimal cut-off admission blood 
glucose value as determined via the receiver operating characteristic curve for predicting in-hospital and 
6-months’ mortality was 8.5mmol/l (area under the curve – AUC 0.63) and 8.1mmol/l (AUC 0.61) for 
MACE, respectively.(5)
CARDIOMYOPATHY AND HEART FAILURE
Isolated left ventricular non-compaction (ILVNC) is a rare, congenital, idiopathic cardiomyopathy that 
may present in adulthood. Lufundo and colleagues described clinical and echocardiographic features in 
four patients, each with a possible diagnosis of ILVNC, in the setting of potential alternative aetiologies 
for heart failure.(6) This case series highlighted the importance of routine echocardiography in patients 
who present with heart failure, irrespective of associated risk factors. The authors cautioned against 
overdiagnosis of ILVNC with transthoracic echocardiography alone and recommended the used of 
cardiovascular magnetic resonance as a confirmatory test which yields additional information. They 
reminded us of the importance of screening of family members and strategies to prevent complications 
in confirmed cases of ILVNC.(6)
HIV-ASSOCIATED CARDIOVASCULAR DISEASE
Dellar, et al. investigated the levels of knowledge of South African surgical patients infected with HIV on 
the diagnosis and CVD. Correct responses for the items on the CVD knowledge questionnaire ranged 
between 0% and 61.5% for risk factors, and between 0% and 89.7% for signs/symptoms for CVD. They 
concluded that knowledge of CVD risk factors, signs and symptoms were less than desirable and that 
levels of CVD knowledge were likely a function of educational attainment.(7)
CARDIAC SURGERY
The systemic inflammatory response associated with cardiopulmonary bypass (CPB) is detrimental to 
organ function in varying degrees. Minimal extracorporeal circulation (MECC) assumes an attenuation of 
these deleterious effects. Swart, et al. compared the conventional CPB (CCPB) with MECC, in a 
4population of patients who had their CABG done in a private practice in South Africa. They 
reported that MECC was associated with a better serum creatinine postoperatively, even though 
dialysis could not be avoided, and that MECC was associated with a shorter hospital stay. The 
second study (CCPB n=63 and MECC n=100) confirmed the shorter hospital stay.(8)
Weich and co-authors reported on the 7-year experience of transcatheter aortic valve implants 
(TAVI) in a private healthcare setting. Patients were high risk, with a mean STS score of 7.89 and 
mean logistic EuroSCORE of 26.5. There was a trend toward lower risk over time. Procedures 
were initially performed mainly via a transapical approach, but changed to mostly transfemoral 
with the introduction of smaller delivery systems. Procedural success rate was 91.8% for 
CoreValve and 88.5% for Edwards cases. Mean length of hospital stay following TAVI was 9 days 
initially, but declined to 4 days. One-year mortality was 19% and 1-year stroke rate was 10%.(9)
Severe mitral annular calcification (MAC) is not an uncommon occurrence in the elderly, and 
presence of MAC often precludes surgical replacement of the mitral valve. Initial attempts 
at percutaneous placement of transcatheter aortic valves in the calcified mitral annulus have 
not been very successful due to obstruction of the left ventricular outflow tract. Weich and 
colleagues describe a novel surgical approach where the anterior mitral valve leaflet was resected 
and a balloon expandable transcatheter aortic valve then successfully deployed within the 
calcified annulus.(10) 
Van der Merwe and colleagues reported on the current status and future perspectives of 
minimally invasive atrioventricular valve surgery.(11) Minimally invasive atrioventricular valve 
surgery (MIAS) is associated with significant learning curves and its routine application is met with 
varying degrees of enthusiasm in view of strict quality control, clinical governance and outcome 
reporting. Whether the reported potential benefits and comparable efficacy across a range of 
long-term outcome measures reported by experienced MIAS centres can be translated into 
general international surgical practice is not clear. 
CONGENITAL HEART DISEASE
Bosman, et al. reported on the safety and efficacy of percutaneous closure of perimembranous 
ventricular septal defects in children. Mean follow-up was 2 years 3 months. Successful device 
delivery was achieved in 97.6%. 71% had complete closure of their defect and 26% had a 
residual but haemodynamically insignificant defect. Significant early complications included 
moderate tricuspid regurgitation and device embolisation in few patients. No cases of heart block 
were recorded.(12)
Lebea and co-authors reported on a single-centre experience with pulmonary valve stenosis 
(PVS) in South Africa and found cases of congenital PVS from between January 1990 and 
January 2016, accounting for 0.0007% of all congenital heart defects during the study period. 
Age at diagnosis ranged from 22 months - 13 years. Most patients presented with respiratory 
symptoms, and some with recurrent haemoptysis. All cases were right-sided unilateral PVS and 
all were associated with one or more congenital heart defects.(13)
Neurodevelopmental evaluation and referral of children with congenital heart disease is an 
important aspect of practice in paediatric cardiology. Smith, et al. report poor awareness of 
management guidelines amongst practitioners, and that 55% of children with developmental 
















Evans and colleagues reported on a 12-week community-based physical activity and mindful-
ness intervention focusing on health outcomes and markers of autonomic nervous system 
function and found that regular physical activity, controlled breathing and stress reduction alter 
heart rate variability – specifically in the low frequency spectrum that is associated with baroreflex 
function.(15) Implications of these changes, in terms of health outcomes, along with efforts at 
addressing scalability and sustainability of community-based health promotion interventions may 
be important targets for future study.
In this issue of the Journal (and the next), we explore a collaboration with the European Society 
of Cardiology on key publications in 2019 in the European Heart Journal. A review and summary 
of key publications related to preventative cardiology,(16) heart failure,(17) imaging,(18) and valvular 
heart disease(19) are included in this issue. More summaries will be included in the next issue. 
Enjoy reading.
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